Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06933836 · ClinicalTrials.gov registry record
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
A clinical trial of Open Angle Glaucoma (OAG), sponsored by Barnet Dulaney Perkins Eye Centers.
- Recruiting
- Registry status
- 55
- Enrollment target
- 1
- Study location
NCT06933836 is a study of Open Angle Glaucoma (OAG) that is actively recruiting participants, run by Barnet Dulaney Perkins Eye Centers. The registered enrollment target is 55 participants, roughly in line with the 57-participant average among 5 other Open Angle Glaucoma (OAG) trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06933836, a study of Open Angle Glaucoma (OAG), is actively recruiting participants, sponsored by Barnet Dulaney Perkins Eye Centers.
- RECRUITING
- Registry status
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Conditions Studied
Interventions
- DEVICE DSLT enables newly diagnosed patients to remain well controlled and off medications
Study Locations (1)
Arizona
- Barnet Dulaney Perkins Eye Centers - Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06933836
The ClinicalTrials.gov registry entry for NCT06933836 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 57-participant average among 5 other Open Angle Glaucoma (OAG) trials with a reported enrollment target. The listed sponsor is Barnet Dulaney Perkins Eye Centers, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Angle Glaucoma (OAG) appearing as the primary indexed condition, and to 1 intervention - of which DSLT enables newly diagnosed patients to remain well controlled and off medications is the first listed.
NCT06933836 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06933836 about?
NCT06933836 is a clinical study titled "DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma". DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
What is the current status of trial NCT06933836?
This trial is currently recruiting. The enrollment target is 55 participants. The study started on 2025-03-31. Estimated completion is 2027-12-31.
What conditions does trial NCT06933836 study?
This clinical trial studies the following conditions: Open Angle Glaucoma (OAG).
What interventions are being tested in trial NCT06933836?
The interventions under investigation include: DSLT enables newly diagnosed patients to remain well controlled and off medications (DEVICE).
Who is sponsoring clinical trial NCT06933836?
This trial is sponsored by Barnet Dulaney Perkins Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06933836 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma (OAG)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
RECRUITING
-
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
RECRUITING · NA
-
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
RECRUITING · Phase 1
-
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
RECRUITING · Phase 2
-
Travoprost Five Day Posology Study
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.